Short term infusion of glycine‐extended gastrin17 stimulates both proliferation and formation of aberrant crypt foci in rat colonic mucosa
暂无分享,去创建一个
[1] S. Watson,et al. Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence , 2000, Gut.
[2] T. Koh,et al. Gastrin as a growth factor in the gastrointestinal tract , 2000, Regulatory Peptides.
[3] T. Wang,et al. Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen. , 2000, Gastroenterology.
[4] T. Wang,et al. Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[5] V. Villanacci,et al. Inhibitory Effect of a Gastrin Receptor Antagonist, CR2945, on 1,2-Dimethylhydrazine-Induced Colorectal Cancer in Mice , 1999, European Surgical Research.
[6] A. Todisco,et al. Glycine-extended gastrin regulates HEK cell growth. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[7] T. Wang,et al. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. , 1999, The Journal of clinical investigation.
[8] A. Todisco,et al. Glycine-Extended Gastrin Exerts Growth-Promoting Effects on Human Colon Cancer Cells , 1999, Molecular medicine.
[9] W. Creutzfeldt,et al. Role of Circulating Gastrin in Colorectal Adenomas and Carcinomas , 1999, Digestion.
[10] B. Evers,et al. JMV1155: a novel inhibitor of glycine-extended progastrin-mediated growth of a human colon cancer in vivo. , 1999, Anticancer research.
[11] S. Polak‐Charcon,et al. Controlled release of TGF‐β1 impedes rat colon carcinogenesis in vivo , 1998, International journal of cancer.
[12] G. Baldwin,et al. Gastrin, gastrin receptors and colorectal carcinoma , 1998, Gut.
[13] G. Baldwin,et al. Expression of progastrin‐derived peptides and gastrin receptors in a panel of gastrointestinal carcinoma cell lines , 1998, Journal of gastroenterology and hepatology.
[14] P. Rumsby,et al. Long-term analysis of colonic aberrant crypt formation after treatment of Sprague-Dawley rats with azoxymethane. , 1998, Teratogenesis, carcinogenesis, and mutagenesis.
[15] G. Ciccotosto,et al. Glycine-extended gastrin acts as an autocrine growth factor in a nontransformed colon cell line. , 1997, Gastroenterology.
[16] H. J. Kim,et al. Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin. , 1997, Gastroenterology.
[17] G. Brandi,et al. Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia , 1997, Gut.
[18] I. Thorup. Histomorphological and immunohistochemical characterization of colonic aberrant crypt foci in rats: relationship to growth factor expression. , 1997, Carcinogenesis.
[19] D. Corpet,et al. Insulin injections promote the growth of aberrant crypt foci in the colon of rats. , 1997, Nutrition and cancer.
[20] T. Wang,et al. Processing and proliferative effects of human progastrin in transgenic mice. , 1996, The Journal of clinical investigation.
[21] T. Wood,et al. Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells. , 1996, Cancer research.
[22] G. Dockray,et al. Gastric endocrine cells: gene expression, processing, and targeting of active products. , 1996, Physiological reviews.
[23] P. O’Brien,et al. Sulindac and indomethacin inhibit formation of aberrant crypt foci in the colons of dimethyl hydrazine treated rats , 1996, Journal of gastroenterology and hepatology.
[24] G. Ciccotosto,et al. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. , 1995, Gastroenterology.
[25] W. Chey. Gut Peptides: Biochemistry and Physiology. , 1995, Gastrointestinal endoscopy.
[26] S. Pignata,et al. Hypergastrinemia in rats with azoxymethane‐induced colon cancers , 1995, International journal of cancer.
[27] B. Kimler,et al. Drug-induced hypergastrinemia: absence of trophic effects on colonic carcinoma in rats. , 1995, Gastroenterology.
[28] M. Wargovich,et al. Inhibition of aberrant crypt growth by non‐steroidal anti‐inflammatory agents and differentiation agents in the rat colon , 1995, International journal of cancer.
[29] C. Seva,et al. Growth-promoting effects of glycine-extended progastrin. , 1994, Science.
[30] P. Singh,et al. Incomplete processing of progastrin expressed by human colon cancer cells: role of noncarboxyamidated gastrins. , 1994, The American journal of physiology.
[31] I. Sobhani,et al. Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa. , 1993, Gastroenterology.
[32] J. Rehfeld,et al. Expression but incomplete maturation of progastrin in colorectal carcinomas. , 1993, Gastroenterology.
[33] J. Rehfeld,et al. Developmental expression of the gastrin and cholecystokinin genes in rat colon. , 1993, Gastroenterology.
[34] D. Appleton,et al. Effects of gastrointestinal peptides on azoxymethane-treated colonic mucosa in vitro. , 1991, Carcinogenesis.
[35] R. Whitehead,et al. Intravenous but not intracolonic epidermal growth factor maintains colonocyte proliferation in defunctioned rat colorectum. , 1990, Gastroenterology.
[36] L. Bardram,et al. Gastrin in non-neoplastic pancreatic tissue from patients with and without gastrinomas. , 1990, Scandinavian journal of gastroenterology.
[37] L. Bardram,et al. Progastrin in serum from Zollinger-Ellison patients. An indicator of malignancy? , 1990, Gastroenterology.
[38] L. Melton,et al. Risk for colorectal adenocarcinoma in pernicious anemia. A population-based cohort study. , 1989, Annals of internal medicine.
[39] R. Hoover,et al. Cancer risk following pernicious anaemia. , 1989, British Journal of Cancer.
[40] E. Riecken,et al. Characterization of stereomicroscopically identified preneoplastic lesions during dimethylhydrazine‐induced colonic carcinogenesis , 1988, European journal of clinical investigation.
[41] R. Bird,et al. Aberrant crypts: potential preneoplastic lesions in the murine colon. , 1988, Cancer research.
[42] R. Bird,et al. Specificity study to evaluate induction of aberrant crypts in murine colons. , 1988, Cancer research.
[43] R P Bird,et al. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. , 1987, Cancer letters.
[44] N. Wright,et al. Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats , 1984, Regulatory Peptides.
[45] E. Hamilton. DIURNAL VARIATION IN PROLIFERATIVE COMPARTMENTS AND THEIR RELATION TO CRYPTOGENIC CELLS IN THE MOUSE COLON , 1979, Cell and tissue kinetics.
[46] E. Fiala. Investigations into the metabolism and mode of action of the colon carcinogens 1,2‐dimethylhydrazine and azoxymethane , 1977, Cancer.